DK1137645T3 - Alfa-methylbenzylholdige thiourinstofinhibitorer af herpesvira indeholdende en phenylendiamingruppe - Google Patents

Alfa-methylbenzylholdige thiourinstofinhibitorer af herpesvira indeholdende en phenylendiamingruppe

Info

Publication number
DK1137645T3
DK1137645T3 DK99963022T DK99963022T DK1137645T3 DK 1137645 T3 DK1137645 T3 DK 1137645T3 DK 99963022 T DK99963022 T DK 99963022T DK 99963022 T DK99963022 T DK 99963022T DK 1137645 T3 DK1137645 T3 DK 1137645T3
Authority
DK
Denmark
Prior art keywords
methylbenzyl
alpha
herpes viruses
phenylenediamine group
thiourea inhibitors
Prior art date
Application number
DK99963022T
Other languages
Danish (da)
English (en)
Inventor
Jonathan David Bloom
Kevin Joseph Curran
Russell George Dushin
Emily Boucher Norton
Adma Antonia Ross
Martin Joseph Digrandi
Stanley Albert Lang
Bryan Mark O'hara
Original Assignee
Wyeth Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wyeth Corp filed Critical Wyeth Corp
Application granted granted Critical
Publication of DK1137645T3 publication Critical patent/DK1137645T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
    • C07D307/82—Benzo [b] furans; Hydrogenated benzo [b] furans with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
    • C07D307/84—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D307/85—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C335/00—Thioureas, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
    • C07C335/04—Derivatives of thiourea
    • C07C335/16—Derivatives of thiourea having nitrogen atoms of thiourea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • C07C335/20—Derivatives of thiourea having nitrogen atoms of thiourea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton being further substituted by nitrogen atoms, not being part of nitro or nitroso groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D215/54—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/02—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines
    • C07D217/06—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines with the ring nitrogen atom acylated by carboxylic or carbonic acids, or with sulfur or nitrogen analogues thereof, e.g. carbamates
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/22—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
    • C07D217/26—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
    • C07D307/79—Benzo [b] furans; Hydrogenated benzo [b] furans with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
    • C07D307/81—Radicals substituted by nitrogen atoms not forming part of a nitro radical

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biotechnology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Hydrogenated Pyridines (AREA)
  • Quinoline Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Furan Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DK99963022T 1998-12-09 1999-12-06 Alfa-methylbenzylholdige thiourinstofinhibitorer af herpesvira indeholdende en phenylendiamingruppe DK1137645T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US20890298A 1998-12-09 1998-12-09

Publications (1)

Publication Number Publication Date
DK1137645T3 true DK1137645T3 (da) 2004-08-09

Family

ID=22776519

Family Applications (1)

Application Number Title Priority Date Filing Date
DK99963022T DK1137645T3 (da) 1998-12-09 1999-12-06 Alfa-methylbenzylholdige thiourinstofinhibitorer af herpesvira indeholdende en phenylendiamingruppe

Country Status (21)

Country Link
EP (1) EP1137645B1 (fr)
JP (1) JP2002531555A (fr)
KR (1) KR20010089551A (fr)
CN (1) CN1165531C (fr)
AR (1) AR035308A1 (fr)
AT (1) ATE267824T1 (fr)
AU (1) AU1934600A (fr)
BR (1) BR9916084A (fr)
CA (1) CA2350833A1 (fr)
CZ (1) CZ20012067A3 (fr)
DE (1) DE69917673T2 (fr)
DK (1) DK1137645T3 (fr)
EA (1) EA004205B1 (fr)
ES (1) ES2221470T3 (fr)
HU (1) HUP0104492A3 (fr)
IL (1) IL143183A0 (fr)
NO (1) NO20012833L (fr)
NZ (1) NZ512135A (fr)
PT (1) PT1137645E (fr)
WO (1) WO2000034260A2 (fr)
ZA (1) ZA200104376B (fr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6844367B1 (en) 1999-09-17 2005-01-18 Millennium Pharmaceuticals, Inc. Benzamides and related inhibitors of factor Xa
WO2001064642A2 (fr) 2000-02-29 2001-09-07 Cor Therapeutics, Inc. Benzamides et inhibiteurs connexes du facteur xa
NZ523882A (en) * 2000-08-21 2004-11-26 Pacific Corp Novel thiourea derivatives and the pharmaceutical compositions containing the same
JP4360885B2 (ja) 2003-11-28 2009-11-11 富士フイルム株式会社 アルキルチオ基を有する芳香族アミン化合物の製造方法
EP1928843A1 (fr) * 2005-08-22 2008-06-11 Amgen, Inc Composes d'uree de bis-aryle pour le traitement de maladies mediees par une proteine kinase
EP2077995B1 (fr) 2006-11-02 2012-02-08 Millennium Pharmaceuticals, Inc. Procédés de synthèse de sels pharmaceutiques d'un inhibiteur du facteur xa
CN112807294B (zh) * 2019-11-18 2023-09-05 武汉大学 一种酰基硫脲类化合物在制备治疗或预防单纯疱疹病毒i型感染药物中的应用
CN115433093A (zh) * 2022-09-26 2022-12-06 无锡双启科技有限公司 一种3-氯-4-三氟甲基苯胺的制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU210683B (en) * 1990-06-18 1995-06-28 Sandoz Ag Process for producing n-benzyl-n1-(phenyl-alkyl)-thiourea derivatives and pharmaceutical compositions containing the same
JPH11503110A (ja) * 1995-02-17 1999-03-23 スミスクライン・ビーチャム・コーポレイション Il−8受容体拮抗剤
GB9519270D0 (en) * 1995-09-21 1995-11-22 Sandoz Pharma Uk Organic compounds
PL192628B1 (pl) * 1996-04-23 2006-11-30 Vertex Pharma Pochodne mocznika, kompozycje farmaceutyczne i zastosowanie związku i kompozycji

Also Published As

Publication number Publication date
NO20012833L (no) 2001-08-02
DE69917673D1 (de) 2004-07-01
PT1137645E (pt) 2004-09-30
CZ20012067A3 (cs) 2001-10-17
ATE267824T1 (de) 2004-06-15
EA200100638A1 (ru) 2001-12-24
HUP0104492A3 (en) 2002-12-28
BR9916084A (pt) 2001-09-04
IL143183A0 (en) 2002-04-21
WO2000034260A2 (fr) 2000-06-15
WO2000034260A3 (fr) 2000-09-08
EP1137645B1 (fr) 2004-05-26
ZA200104376B (en) 2002-08-28
AU1934600A (en) 2000-06-26
NZ512135A (en) 2003-12-19
CA2350833A1 (fr) 2000-06-15
CN1329608A (zh) 2002-01-02
HUP0104492A2 (hu) 2002-04-29
KR20010089551A (ko) 2001-10-06
AR035308A1 (es) 2004-05-12
CN1165531C (zh) 2004-09-08
ES2221470T3 (es) 2004-12-16
DE69917673T2 (de) 2005-06-09
EA004205B1 (ru) 2004-02-26
JP2002531555A (ja) 2002-09-24
NO20012833D0 (no) 2001-06-08
EP1137645A2 (fr) 2001-10-04

Similar Documents

Publication Publication Date Title
ATE245142T1 (de) No-synthase inhibitoren
DK1049662T3 (da) Inhibitorer af alpha4-medieret celleadhæsion
DK1027332T3 (da) Hidtil ukendte lactametalloproteaseinhibitorer
DK0958287T3 (da) Sulfamidmetalloprotease-inhibitorer
PT1047450E (pt) Combinacoes inibidor ace - inibidor mmp
DE69900356D1 (de) Nitro-Isoharnstoffderivate
DK1107980T3 (da) Krystallinske former af EtO2C-CH2-(R)Cgl-Aze-Pab-OH
IS5772A (is) Þalazín (phthalazine) afleiður af fosfódíesterasa4 lötum
DE69819803D1 (de) Heisschmelzende Tinte
NO20005795D0 (no) Antivirale forbindelser
NO20012834D0 (no) Acetamid- og substituerte acetamid-holdige tioureainhibitorer for herpesvirus
DK1137632T3 (da) Thiourinstofinhibitorer af herpesvira
ID23780A (id) Nitrik oksida penghambat infeksi phinovirus
IL143182A0 (en) Heterocyclic carboxamide-containing thiourea inhibitors of herpes viruses containing phenylenediamine group
IL143263A0 (en) Heterocyclic carboxamide-containing thiourea inhibitors of herpes viruses containing a substituted phenylenediamine group
HUP0104492A3 (en) Alpha-methylbenzyl-containing thiourea inhibitors of herpes viruses containing a phenylenediamine group
NO20012836D0 (no) Tiourea-inhibitorer for herpes virus
DK1102747T3 (da) Krystalformer af osenetant
DK0980241T3 (da) Gelatineindkapslede opløsningsdosisformer af sertralin
NO20012837D0 (no) Tiourea-inhibitorer for herpesvirus
DK0949245T3 (da) Fremgangsmåde til alkylering af hindrede sulfonamider
DE69838855D1 (de) Kettenrad
DE59903701D1 (de) Mehrfachpackung
NO992858D0 (no) Inhibitor for portahypertensjon
SI1137645T1 (en) Alpha-methylbenzyl-containing thiourea inhibitors of herpes viruses containing a phenylenediamine group